Shrikumar Suryanarayan of Sea6Energy takes over as ABLE President

2018-04-03 23:05:46

A new team of elected Executive Council, led by  Mr Shrikumar Suryanarayan, chairman of Sea6Energy, as President has taken charge at the Association of Biotechnology Led Enterprises (ABLE) on April 1, 2018.By Team ABLEABLE’s new executive committee  led by Shrikumar Suryanarayan  was , elected in November 2017. The team will hold office for the next three years, up to March 31, 20

Read more

“Jerky policies are a deterrent to biotech growth” Dr PM Murali

2018-03-30 07:27:42

DR PANCHAPAGESA MUTHUSWAMY MURALI takes a bow as the President of ABLE on March 31, 2018 after an illustrious three-year tenure as the CEO of India’s biotechnology industry organization, ABLE. This was his second three-year tenure at the helm of ABLE, starting in 2012. During the past years, ABLE has transformed from a small organization

Read more

Dr. Javed N Agrewala bags ‘JC Bose Fellowship’ Award

2018-03-29 09:16:58

Dr Javed of IIT Ropar has been awarded the ‘JC Bose Fellowship’ for his work on the development of novel vaccination strategies against tuberculosis.By Team ABLEDr. Javed N Agrewala, Professor, Centre for Biomedical Research, Indian Institute of Technology Ropar has been awarded the prestigious ‘JC Bose Fellowship’ for his work on the development of novel vaccination strategies against tub

Read more

Prof. K VijayRaghavan appointed as Principal Scientific Adviser to India

2018-03-29 09:15:35

Prof. K VijayRaghavan was appointed the Principal Scientific Adviser to the Government of India. He succeeds Dr. R. ChidambaramBy Team ABLEIt was announced on March 26, 2018, that ex-Secretary, Department of Biotechnology (DBT) and ex-Director of the National Centre for Biological Sciences (NCBS), Prof. K VijayRaghavan was appointed the Principal Scientific Adviser to the Government of India. He s

Read more

No GST on Research Services; Provisions under Section 13 (3)(a) regularized

2018-03-29 08:44:45

GST on R&D services involving R&D, prototyping, manufacturing arrangements, in-house development of molecules, testing processes, and other services, where reference material is supplied, now clarified.  By Team ABLEThe union government has in principle agreed to waive GST by regularizing the research services and export of services sections related to pharmaceuticals and biotechnolog

Read more

genedrive signs distribution agreement with ARKRAY Healthcare for RNA Assay

2018-03-29 02:12:19

Genedrive HCV ID Kit is a qualitative HCV RNA assayBy Team ABLEgenedrive plc, the near patient molecular diagnostics company, has signed a distribution agreement with ARKRAY Healthcare pvt Ltd, a wholly owned subsidiary of IVD company ARKRAY Inc. Japan, for its CE marked Genedrive HCV ID Kit and Genedrive platform in India.Under the agreement, genedrive will retain responsibility for product devel

Read more

Mylan, Biocon receive European Commission and TGA Australia approvals for Biosimilar Insulin Glargine, Semglee

2018-03-29 02:10:53

Mylan plans to launch Semglee in Australia later this year and expects to begin launching the product across various markets in Europe in the second half of 2018.By Team ABLEMylan N.V. and Biocon Ltd have announced that their co-developed biosimilar insulin glargine Semglee has received marketing authorization approval from the European Commission (EC) following the positive recommendation by the

Read more

Animal health companies Boehringer Ingelheim, KMOH, ZNWT to launch Vaccine JV in China

2018-03-29 02:09:44

The venture is expected to introduce a vaccine technology and expertise against foot-and-mouth disease in a bid to shape the future market in China. By Team ABLEShaanxi Meili Omni-Honesty Animal Health Co., Ltd., China’s vaccine company targeting foot-and-mouth disease in swine, was launched on March 24th with a groundbreaking ceremony held at the Airport New City in Xi’an, capital city of Sha

Read more

Applications for Africa-India Mobility Fund opens on April 3, 2018

2018-03-29 02:08:37

Africa-India Mobility Fund (AIMF) is a two-year program designed to provide researchers from Africa and India with opportunities for short visits in either direction to explore opportunities for building and strengthening scientific collaborationBy Team ABLEThe Wellcome Trust/DBT India Alliance (India Alliance), in partnership with African Academy of Sciences has launched the Africa-India Mobility

Read more

Syngene-GSK ink drug discovery pact

2018-03-27 07:23:26

The multi-year R&D agreement between the two companies will focus on accelerating the discovery of new drug candidates using Syngene’s discovery services platformsBy Team ABLEGlobally acclaimed Biotech major Biocon’s contract research arm Syngene International has inked a drug discovery agreement with biopharma giant GSK.The multi-year R&D agreement between the two companies will focus

Read more